The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): First results of overall survival (OS) from CheckMate 577.
 
Ronan Kelly
Honoraria - Cardinal Health
Consulting or Advisory Role - Amgen; Aptitude Health; Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Clinical Education Alliance; Daiichi Sanyo; Eisai; Exact Sciences; Gilead Sciences; Jazz Pharmaceuticals; Medical Learning Group; Merck; MJH Life Sciences; Novocure; Onc Live; Oncohost; Peerview; Targeted Oncology; Toray Industries
Speakers' Bureau - Astellas Pharma; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Merck
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst)
Expert Testimony - Bristol-Myers Squibb
Travel, Accommodations, Expenses - bristol-myers squibb
 
Jaffer Ajani
Honoraria - Acrotech Biopharma; Aduro Biotech; Amgen; Astellas Pharma; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; DAVA Pharmaceuticals; Fresenius Kabi; Gilead Sciences; GRAIL; Lilly; Merck; Novartis; oncotherics; SERVIER; zymeworks
Consulting or Advisory Role - American Cancer Society; Amgen; Astellas Pharma; BeiGene; BeiGene; Bristol-Myers Squibb; Geneos; Gilead Sciences; Jazz Pharmaceuticals; Kyowa Kirin International; Merck; Novartis; SERVIER; Vaccinogen; Zymeworks
Research Funding - Amgen; Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb; Daiichi Sankyo; Delta-Fly Pharma; Gilead Sciences; Lilly/ImClone; Merck; Novartis; ProLynx; Roche/Genentech; SERVIER (Inst); Taiho Pharmaceutical; Takeda; Zymeworks
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly
 
Jaroslaw Kuzdzal
Honoraria - AstraZeneca
Research Funding - Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Thomas Zander
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Novartis
 
Eric Van Cutsem
Consulting or Advisory Role - Abbvie; Agenus; ALX Oncology; Amgen; Arcus Biosciences; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bexon Clinical Consulting; BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb; Cantargia AB; Daiichi Sankyo; Debiopharm Group; Eisai; ElmediX; Fosum; Galapagos NV; GlaxoSmithKline; Ipsen; ITeos Therapeutics; Lilly; Merck KGaA; Merck Sharp & Dohme; Microbial Machines; Mirati Therapeutics; Nordic Group; Novartis; Novocure; Pfizer; Pierre Fabre; Sanofi; Seagen; SERVIER; Simcere; Taiho Pharmaceutical; Takeda; Trishula Therapeutics
 
Guillaume Piessen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Elivie; MSD Oncology; Nestle health science; Stryker
Travel, Accommodations, Expenses - Elivie; medtronic; MSD Oncology
Other Relationship - elivie
(OPTIONAL) Uncompensated Relationships - Medtronic
 
Guillermo Mendez
Honoraria - Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; MSD; Pfizer
Consulting or Advisory Role - AstraZeneca; BeiGene; Bristol-Myers Squibb; MSD; Pfizer; SERVIER; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; MSD; Pfizer
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Pfizer
 
Josephine Feliciano
Consulting or Advisory Role - AstraZeneca; bristol myers; Coherus Biosciences; daichi; Genentech; Janssen; Lilly; Lilly; Merck; Pfizer; regeneron
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); bms (Inst); Bristol Myers (Inst); genentech; Merck; Pfizer (Inst)
Travel, Accommodations, Expenses - Regeneron
 
Satoru Motoyama
No Relationships to Disclose
 
Astrid Lievre
Honoraria - Advanced Accelerator Applications; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb (Mexico); Esteve; Incyte; Ipsen; LEO Pharma; Mylan; Novartis; Pierre Fabre; Roche; SERVIER; Viatris
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bristol-Myers Squibb (Mexico); Incyte; Pierre Fabre; SERVIER
Research Funding - Bayer (Inst); IntegraGen (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Ipsen; MSD Oncology; Mylan; Pierre Fabre; Roche; SERVIER; Viatris
 
Hope Uronis
Employment - GeneCentric (I)
Stock and Other Ownership Interests - GeneCentric (I)
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex
Research Funding - Arcus Biosciences (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Leap Therapeutics (Inst); Macrogenics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb
 
Elena Elimova
Employment - Merck (I)
Honoraria - Daiichi Sankyo/Astra Zeneca; Roche Canada
Consulting or Advisory Role - Abbvie; Adaptimmune (Inst); Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Signatera; Viracta Therapeutics; Zymeworks (Inst)
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); AstraZeneca Canada (Inst); Bold Therapeutics (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Jazz Pharmaceuticals (Inst); Zymeworks (Inst)
 
Cecile Grootscholten
No Relationships to Disclose
 
Karen Geboes
Consulting or Advisory Role - AstraZeneca (Inst); BeiGene (Inst); BMS (Inst); Ipsen (Inst); Pierre Fabre (Inst); SERVIER (Inst)
Speakers' Bureau - BMS (Inst); Ipsen (Inst)
Expert Testimony - servier (Inst)
Travel, Accommodations, Expenses - Ipsen (Inst); MSD (Inst); servier (Inst)
 
Jenny Zhang
Employment - Bristol Myers Squibb Foundation
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Stephen McCraith
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Beilei He
Employment - Bristol-Myers Squibb/Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene
 
Ming Lei
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
 
James Cleary
Honoraria - AstraZeneca; Blueprint Medicines; Gilead Sciences; Incyte; Syros Pharmaceuticals
Research Funding - Amgen; Apexigen; Arcus Biosciences; Arcus Biosciences; AstraZeneca; Bayer; BMS (Inst); BMS (Inst); Esperas Pharma; Merck; Merus (Inst); Roche/Genentech (Inst); SERVIER (Inst); Tesaro
Travel, Accommodations, Expenses - Agios; Bristol-Myers Squibb; Gilead Sciences; Incyte; Roche
 
Markus Moehler
Honoraria - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Bayer Schering Pharma; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Idience; Merck Serono; MSD Oncology; Pierre Fabre; Transcenta; Triptych Health Partners
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; BMS; Daiichi Sankyo Europe GmbH; Lilly; Merck Serono; MSD; SERVIER; Taiho Pharmaceutical; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Leap Therapeutics (Inst); Merck Serono (Inst); MSD (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Amgen; ASCO; Bayer; BeiGene; ESMO; German Cancer Society; Merck Serono; MSD; Roche; Sanofi Pasteur